Don't Be Surprised to See Additional Meds Used for COVID-19

March 2021

You'll hear more about using tocilizumab or ivermectin to treat patients hospitalized with COVID-19.

Tocilizumab (Actemra) is an injectable "IL-6 inhibitor" that may help reduce the risk of death in certain COVID-19 inpatients.

But tocilizumab has downsides...such as an increased risk for serious infections and a price tag of up to $4,600/dose.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

COVID-19 Prevent Pitfalls With Vaccines and Treatments for COVID-19
Communication Don't Shy Away From Communicating Concerns to Colleagues
COVID-19 Be Familiar With the New Viral Vector Vaccine for COVID-19
Injectables Use Strategies to Ensure Safety With IM Meds
COVID-19 Don't Be Surprised to See Additional Meds Used for COVID-19
Pediatrics Avoid Mishaps When Dispensing Meds for "NOWS"
HIV & AIDS Watch for Cabenuva, a New Monthly Injectable for HIV
Immunizations Reduce the Risk of Pain or Injury From IM Vaccinations
Overactive Bladder Think of Gemtesa as Similar to Myrbetriq for Overactive Bladder